Monsenso digital health solution is HIPAA compliant

Monsenso digital health solution is HIPAA compliant

Monsenso A/S, a technology leader in digital health solutions for mental health is HIPAA compliant. The Monsenso digital health solution that connects individuals and clinicians to provide optimal care adheres to the highest standards for data security and privacy. In addition to being HIPAA compliant, Monsenso holds ISO 13485 and ISO 27001 certifications, Cyber Essentials certification, a TGA certification and class 1 CE mark.

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) was enacted by the U.S. Department of Health and Human Services (HHS) and is a federal law that mandates the creation of national standards to protect patients’ sensitive health information from disclosure without their consent or knowledge.

To read more about our data protection, download our Data management & Security fact sheet.

About Monsenso

Monsenso is an innovative technology company offering a digital health solution. Our mission is to help provide better mental health to more people at lower costs. Our solution helps optimise the treatment of mental disorders and gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. Based on continuous research and development, our team is committed to developing solutions that fit seamlessly into the lives of individuals, increase their quality of life and improve the efficacy of mental health treatment. To learn more visit www.monsenso.com.

For additional information contact:

Bettina van Wylich-Muxoll
Chief Marketing Officer
Monsenso
+45 22 70 47 24
marketing@monsenso.com

Monsenso signs a contract with Centre for Social Psychiatry and Substance Abuse in Aabenraa municipality, Denmark.

Monsenso signs a contract with Centre for Social Psychiatry and Substance Abuse in Aabenraa municipality, Denmark.

Monsenso signs a contract with the Centre for Social Psychiatry and Substance Abuse in the municipality of Aabenraa in Denmark. The Monsenso digital health solution will be integrated as part of the treatment of citizens living in supported housing to help reduce relapses and re-admissions.

To reduce relapses and re-admissions of citizens suffering from mental disorders and substance abuse, the Centre for Social Psychiatry in Aabenraa Municipality has decided to offer the Monsenso digital health solution as an integrated part of their services in supported housing.

The citizens will be provided with the Monsenso app to keep track of their well-being, symptoms, and medication intake through self-reported data, as well as their behaviour through sensor data collected on mobile phones, sleep mats and watches. The historical data is visualised and helps the citizens remember how they have been doing when they speak with the housing support staff and gain better insight into the behaviours that trigger their symptoms, empowering them to better manage their condition.

The housing support staff access the data via a web portal enabling them to see fluctuations in the mental state of the citizens, hereby offering the opportunity to predict relevant outcomes for mood disorders and reduce potential relapses and readmissions.

The Monsenso app also provides treatment support in the form of Tools & Challenges and Action Plans for coping strategies that citizens can use to overcome stress and abandonment related to daily tasks.

“We are very excited about this project because the solution helps individuals take a more active role in their recovery process. The data captured provides the individuals with insight on how their lifestyle affects their mental well-being, empowering them to make positive changes” says Henning Iversen, Head of Housing Services at Aabenraa Municipality.

“We are excited to see Monsenso digital health solution integrated into the care of citizens living in supported housing.” said Thomas Lethenborg, CEO of Monsenso. “We know that one of the most important components to reducing relapse and increasing mental wellbeing is having the tools to better manage your condition”.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso